Related references
Note: Only part of the references are listed.Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux
Svetlana Diditchenko et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Jan H. Cornel et al.
AMERICAN HEART JOURNAL (2012)
ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies
Stephen J. Nicholls et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport
Robert S. Rosenson et al.
CIRCULATION (2012)
A Gene Expression Signature That Classifies Human Atherosclerotic Plaque by Relative Inflammation Status
Oscar Puig et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2011)
Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease A Randomized Controlled Trial
Stephen J. Nicholls et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
A Prospective Natural-History Study of Coronary Atherosclerosis.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells
Jonathan E. Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?
Jean-Claude Tardif
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
Ron Waksman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
High-Density Lipoprotein/Apolipoprotein A-I Infusion Therapy
Jean-Claude Tardif et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
James A. Shaw et al.
CIRCULATION RESEARCH (2008)
One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United States
Elizabeth M. Mahoney et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2008)
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia
D. Maccubbin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes - A meta-analysis of randomized controlled trials
M Briel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
In-hospital initiation of statin therapy in acute coronary syndromes - Maximizing the early and long-term benefits
GC Fonarow
CHEST (2005)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)